Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (453)	3/1/1999 2:49:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 4974

Very interesting, and a very good nomination. I think that I'm going to lean toward GLIA..... a brand new class of agents going into humans, and looking good through single-dose phase I. In any event, I will only vote one vote today. Remember... the intent is to identify news that will change biotech going forward. The GILD/NXTR news is almost a no-brainer, but.... I like the GLIA news..... the company has a chance to be a mega-bagger. A few more mega-baggers is just what we need right now.